Search CommunityWalk:


LeukoSight Inc.

1107 Microbiology Building, 231 B Campus Drive
College Park, MD, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

LeukoSight Inc. is a biotechnology company focused on the development of therapeutics that can be used to treat autoimmune and inflammatory diseases. The company was founded by David Mosser.

LeukoSight's technology offers a convenient, safe and more effective treatment option for autoimmune and inflammatory diseases.

LeukoSight has developed a line of proprietary recombinant polypeptides that "reprogram" white blood cells (leukocytes) to produce immunoregulatory molecules. Its therapeutic platform is directed at treating the most prominent of autoimmune and inflammatory diseases, including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.